Universe Pharmaceuticals (UPC) Common Equity (2020 - 2026)
Universe Pharmaceuticals (UPC) posted Common Equity of $55.6 million for Q1 2026, down 0.86% sequentially from $56.1 million in Q3 2025.
Universe Pharmaceuticals (UPC) Common Equity (2020 - 2026) Analysis & Trends
Universe Pharmaceuticals has reported Common Equity for 7 years, with the latest figure at $55.6 million in Q1 2026.
- Quarterly Common Equity changed N/A year-over-year to $55.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.6 million (changed N/A YoY) and the FY2025 annual result came in at $56.1 million, up 23.35% from the prior year.
- Common Equity fell to $55.6 million in Q1 2026 per UPC's latest filing, from $56.1 million in the prior quarter.
- Over five years, Common Equity peaked at $35.3 billion in Q3 2022 and troughed at $26.7 million in Q1 2024.
- A 5-year average of $7.9 billion and a median of $55.9 million in 2025 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2024: Common Equity surged 75083.64% in 2022, then tumbled 99.84% in 2024.
- Over 5 years, Common Equity stood at $35.3 billion in 2022, then dropped by 20.83% to $28.0 billion in 2023, then sank by 99.84% to $45.5 million in 2024, then grew by 23.35% to $56.1 million in 2025, then slipped by 0.86% to $55.6 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $55.6 million, $56.1 million, and $45.5 million for Q1 2026, Q3 2025, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Universe Pharmaceuticals | 3.04 Mn | -26.01 Mn | - | 55.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.65 Mn |
| Sep 30, 2025 | 56.13 Mn |
| Sep 30, 2024 | 45.50 Mn |
| Mar 31, 2024 | 26.74 Mn |
| Sep 30, 2023 | 27.97 Bn |
| Mar 31, 2023 | 47.13 Mn |
| Sep 30, 2022 | 35.33 Bn |
| Mar 31, 2022 | 61.16 Mn |
| Sep 30, 2021 | 46.99 Mn |
| Sep 30, 2020 | 20.80 Mn |